Diagnostic Challenges in the Cytology of Thymic Epithelial Neoplasms

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2022 Apr 23

PMID 35454918

Authors

Jonathan Willner

Fang Zhou

Andre L Moreira

Affiliations

Soon will be listed here.

Abstract

Thymic epithelial neoplasms are rare tumors that constitute the majority of anterior mediastinal masses. They are classified as thymomas, thymic carcinomas, and thymic neuroendocrine neoplasms. Biopsy diagnosis is not common, and most tumors are surgically resected. Biopsy, including cytology, is indicated when a non-surgical entity is suspected or in cases of locally advanced disease. Smears of thymomas consist of round or spindle epithelial cells admixed with varying amounts of lymphocytes depending on the type of thymoma. Smears of thymic carcinoma and thymic neuroendocrine neoplasms are often indistinguishable from corresponding tumor types from other organs. Accurate cytological diagnosis can be difficult due to the histological diversity of thymomas, as well as the morphological features that certain thymic tumors share with similar tumors from other organs. However, fine needle aspiration (FNA) of anterior mediastinal masses can provide clinically actionable information and can be used to determine whether lesions require surgical, systemic, or local noninvasive treatments. Ancillary studies, namely, immunocytochemical stains, flow cytometry, and radiology, are important tools in the evaluation of thymic aspirates. This review discusses the utility and limitations of thymic FNAs and illustrates the diagnostic features and pitfalls of these specimens.

Citing Articles

Clinical features of thymoma with and without myasthenia gravis.

Wang Y, Qi G, Yang Y, Yang H Pak J Med Sci. 2024; 40(7):1384-1390.

PMID: 39092039 PMC: 11255815. DOI: 10.12669/pjms.40.7.8698.

Immunotherapy in thymic epithelial tumors: tissue predictive biomarkers for immune checkpoint inhibitors.

Luca S, Accardo M, Campione S, Franco R Explor Target Antitumor Ther. 2024; 5(3):465-476.

PMID: 38966177 PMC: 11220306. DOI: 10.37349/etat.2024.00229.

The Utility of Fine Needle Aspiration (FNA) Biopsy in the Diagnosis of Mediastinal Lesions.

Kundu U, Gan Q, Donthi D, Sneige N Diagnostics (Basel). 2023; 13(14).

PMID: 37510144 PMC: 10378189. DOI: 10.3390/diagnostics13142400.

Current Treatment Approaches for Thymic Epithelial Tumors.

Tartarone A, Lerose R, Lettini A, Tartarone M Life (Basel). 2023; 13(5).

PMID: 37240815 PMC: 10222654. DOI: 10.3390/life13051170.

Minimally Invasive Cytopathology and Accurate Diagnosis: Technical Procedures and Ancillary Techniques.

Huang C, Luo X, Wang S, Wan Y, Wang J, Tang X In Vivo. 2023; 37(1):11-21.

PMID: 36593030 PMC: 9843757. DOI: 10.21873/invivo.13050.

References

Padda S, Keijzers M, Wakelee H . Pretreatment biopsy for thymic epithelial tumors-does histology subtype matter for treatment strategy?. J Thorac Dis. 2016; 8(8):1895-900. PMC: 4999713. DOI: 10.21037/jtd.2016.06.77. View

Pina-Oviedo S, Moran C . Primary Mediastinal Classical Hodgkin Lymphoma. Adv Anat Pathol. 2016; 23(5):285-309. DOI: 10.1097/PAP.0000000000000119. View

Kalhor N, Moran C . Primary thymic adenocarcinomas: a clinicopathological and immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation. Hum Pathol. 2018; 74:73-82. DOI: 10.1016/j.humpath.2018.01.011. View

Dermawan J, Mukhopadhyay S, Shah A . Frequency and extent of cytokeratin expression in paraganglioma: an immunohistochemical study of 60 cases from 5 anatomic sites and review of the literature. Hum Pathol. 2019; 93:16-22. DOI: 10.1016/j.humpath.2019.08.013. View

Liau J, Tsai J, Jeng Y, Kuo K, Huang H, Liang C . The Diagnostic Utility of PAX8 for Neuroendocrine Tumors: An Immunohistochemical Reappraisal. Appl Immunohistochem Mol Morphol. 2015; 24(1):57-63. DOI: 10.1097/PAI.0000000000000149. View

Kojika M, Ishii G, Yoshida J, Nishimura M, Hishida T, Ota S . Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms. Mod Pathol. 2009; 22(10):1341-50. DOI: 10.1038/modpathol.2009.105. View

Oramas D, Moran C . Thymoma: Challenges and Pitfalls in Biopsy Interpretation. Adv Anat Pathol. 2021; 28(5):291-297. DOI: 10.1097/PAP.0000000000000310. View

Hishima T, Fukayama M, Fujisawa M, Hayashi Y, Arai K, Funata N . CD5 expression in thymic carcinoma. Am J Pathol. 1994; 145(2):268-75. PMC: 1887382. View

Bille A, Sachidananda S, Moreira A, Rizk N . Unusual late presentation of metastatic extrathoracic thymoma to gastrohepatic lymph node treated by surgical resection. Gen Thorac Cardiovasc Surg. 2015; 65(2):130-132. DOI: 10.1007/s11748-015-0604-1. View

10.

Dinter H, Bohnenberger H, Beck J, Bornemann-Kolatzki K, Schutz E, Kuffer S . Molecular Classification of Neuroendocrine Tumors of the Thymus. J Thorac Oncol. 2019; 14(8):1472-1483. DOI: 10.1016/j.jtho.2019.04.015. View

11.

Shin H, Katz R . Thymic neoplasia as represented by fine needle aspiration biopsy of anterior mediastinal masses. A practical approach to the differential diagnosis. Acta Cytol. 1998; 42(4):855-64. DOI: 10.1159/000331959. View

12.

Du E, Goldstraw P, Zacharias J, Tiffet O, Craig P, Nicholson A . TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol. 2004; 35(7):825-31. DOI: 10.1016/j.humpath.2004.02.016. View

13.

Carter B, Benveniste M, Madan R, Godoy M, de Groot P, Truong M . ITMIG Classification of Mediastinal Compartments and Multidisciplinary Approach to Mediastinal Masses. Radiographics. 2017; 37(2):413-436. DOI: 10.1148/rg.2017160095. View

14.

Mendogni P, Toker A, Moser B, Trancho F, Aigner C, Bravio I . Surgical resection of Masaoka stage III thymic epithelial tumours with great vessels involvement: a retrospective multicentric analysis from the European Society of Thoracic Surgeons thymic database. Eur J Cardiothorac Surg. 2022; 62(4). DOI: 10.1093/ejcts/ezac021. View

15.

Ruffini E, Mancuso M, Oliaro A, Casadio C, Cavallo A, Cianci R . Recurrence of thymoma: analysis of clinicopathologic features, treatment, and outcome. J Thorac Cardiovasc Surg. 1997; 113(1):55-63. DOI: 10.1016/S0022-5223(97)70399-4. View

16.

Kattach H, Hasan S, Clelland C, Pillai R . Seeding of stage I thymoma into the chest wall 12 years after needle biopsy. Ann Thorac Surg. 2004; 79(1):323-4. DOI: 10.1016/j.athoracsur.2003.08.004. View

17.

Renshaw A, Haja J, Neal M, Wilbur D . Distinguishing carcinoid tumor of the mediastinum from thymoma: correlating cytologic features and performance in the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytopathology. Arch Pathol Lab Med. 2006; 130(11):1612-5. DOI: 10.5858/2006-130-1612-DCTOTM. View

18.

Zhao J, Bhatnagar V, Ding L, Atay S, David E, McFadden P . A systematic review of paraneoplastic syndromes associated with thymoma: Treatment modalities, recurrence, and outcomes in resected cases. J Thorac Cardiovasc Surg. 2020; 160(1):306-314.e14. DOI: 10.1016/j.jtcvs.2019.11.052. View

19.

Illei P, Shyu S . Fine needle aspiration of thymic epithelial neoplasms and non-neoplastic lesions. Semin Diagn Pathol. 2020; 37(4):166-173. DOI: 10.1053/j.semdp.2020.04.006. View

20.

Temes R, Chavez T, Mapel D, Ketai L, Crowell R, Key C . Primary mediastinal malignancies: findings in 219 patients. West J Med. 1999; 170(3):161-6. PMC: 1305534. View